Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ADMA Biologics Inc (ADMA : NSDQ)

• Company Description    ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. ADMA Biologics, Inc. is headquartered in Ramsey, New Jersey. Number of Employees: 685

• Price / Volume Information    Yesterday's Closing Price: $18.24 Daily Weekly Monthly 20 Day Moving Average: 1,981,673 shares Shares Outstanding: 238.00 (millions) Market Capitalization: $4,341.08 (millions) Beta: 0.47 52 Week High: $25.67 52 Week Low: $13.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -9.30% -9.14% 12 Week 23.75% 21.75% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 465 STATE ROUTE 17 - RAMSEY,NJ 07446 USA ph: 201-478-5552 fax: 201-478-5553 michelle@argotpartners.com http://www.admabiologics.com

• General Corporate Information    Officers Adam S. Grossman - President and Chief Executive Officer Steven A. Elms - Chairman Jerrold B. Grossman - Vice Chairman Brad Tade - Chief Financial Officer Alison Finger - Director Peer Information ADMA Biologics Inc (CORR.) ADMA Biologics Inc (RSPI) ADMA Biologics Inc (CGXP) ADMA Biologics Inc (BGEN) ADMA Biologics Inc (GTBP) ADMA Biologics Inc (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 000899104 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/02/26 Share - Related Items Shares Outstanding: 238.00 Most Recent Split Date: (:1) Beta: 0.47 Market Capitalization: $4,341.08 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.82 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/02/26

• Fundamental Ratios P/E Current FY Estimate: 22.24 Trailing 12 Months: 30.92 PEG Ratio: - Price Ratios Price/Book: 10.08 Price/Cash Flow: 33.70 Price / Sales: 8.89 EPS Growth vs. Year Ago Period: 6.67% vs. Previous Quarter: 6.67% Sales Growth vs. Year Ago Period: 12.00% vs. Previous Quarter: 10.03% ROE 12/31/25 - - 09/30/25 - 36.52 06/30/25 - 41.01 ROA 12/31/25 - - 09/30/25 - 26.65 06/30/25 - 28.47 Current Ratio 12/31/25 - - 09/30/25 - 7.13 06/30/25 - 5.33 Quick Ratio 12/31/25 - - 09/30/25 - 3.65 06/30/25 - 2.78 Operating Margin 12/31/25 - - 09/30/25 - 29.00 06/30/25 - 29.25 Net Margin 12/31/25 - - 09/30/25 - 42.87 06/30/25 - 44.06 Pre-Tax Margin 12/31/25 - - 09/30/25 - 31.89 06/30/25 - 30.58 Book Value 12/31/25 - - 09/30/25 - 1.81 06/30/25 - 1.67 Inventory Turnover 12/31/25 - - 09/30/25 - 1.21 06/30/25 - 1.26 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.18 06/30/25 - 0.21 Debt-to-Capital 12/31/25 - - 09/30/25 - 15.56 06/30/25 - 17.19

Powered by Zacks Investment Research ©